Prostate stem cell antigen, a presumable organ-dependent tumor suppressor gene, is down-regulated in gallbladder carcinogenesis

Genes Chromosomes and Cancer

Volumn 51, Issue 1, 2012, Pages 30-41

  Ono, Hiroe ^a,b   Hiraoka, Nobuyoshi ^a   Lee, Yeon Su ^c   Woo, Sang Myung ^c   Lee, Woo Jin ^c   Choi, Il Ju ^c   Saito, Akira ^d   Yanagihara, Kazuyoshi ^e   Kanai, Yae ^a   Ohnami, Sumiko ^a   Chiwaki, Fumiko ^a   Sasaki, Hiroki ^a   Sakamoto, Hiromi ^a   Yoshida, Teruhiko ^a   Saeki, Norihisa ^a  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c National Cancer Center   (South Korea)

^d Kuramae Orashion Bldg 9F   (Japan)

^e YASUDA WOMEN'S UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE STEM CELL ANTIGEN;

ARTICLE; CANCER CELL CULTURE; CARCINOGENESIS; CHOLECYSTITIS; CHOLELITHIASIS; CHOLESTEROSIS; CONTROLLED STUDY; DOWN REGULATION; GALLBLADDER ADENOCARCINOMA; GALLBLADDER CANCER; GALLBLADDER DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ANTIGENS, NEOPLASM; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; CHOLECYSTITIS; DNA METHYLATION; DOWN-REGULATION; EPITHELIUM; GALLBLADDER; GALLBLADDER NEOPLASMS; GENES, TUMOR SUPPRESSOR; GPI-LINKED PROTEINS; HUMANS; MALE; NEOPLASM PROTEINS; PROMOTER REGIONS, GENETIC;

EID: 80455176960     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20928     Document Type: Article

References (41)

1. Albores-Saavedra J, Scoazec JC, Wittekind C, Sripa B, Menck HR, Soehendra N, Sriram PVJ. 2000. Tumours of the gallbladder and extrahepatic bile ducts. In: Hamilton R, Lauri AA, editors. In World Health Organization Classification of Tumors: Pathology & Genetics: Tumors of the Digestive System. Lyon: IARC, pp. 206-214.
2. Amara N, Palapattu GS, Schrage M, Gu Z, Thomas GV, Dorey F, Said J, Reiter RE. 2001. Prostate stem cell antigen is overexpressed in human transitional cell carcinoma. Cancer Res 61: 4660-4665.
3. Argani P, Rosty C, Reiter RE, Wilentz RE, Murugesan SR, Leach SD, Ryu B, Skinner HG, Goggins M, Jaffee EM, Yeo CJ, Cameron JL, Kern SE, Hruban RH. 2001. Discovery of new markers of cancer through serial analysis of gene expression: Prostate stem cell antigen is overexpressed in pancreatic adenocarcinoma. Cancer Res 61: 4320-4324.
4. Bahrenberg G, Brauers A, Joost HG, Jakse G. 2000. Reduced expression of PSCA, a member of the LY-6 family of cell surface antigens, in bladder, esophagus, and stomach tumors. Biochem Biophys Res Commun 275: 783-788.
5. Cao D, Ji H, Ronnett BM. 2005. Expression of mesothelin, fascin, and prostate stem cell antigen in primary ovarian mucinous tumors and their utility in differentiating primary ovarian mucinous tumors from metastatic pancreatic mucinous carcinomas in the ovary. Int J Gynecol Pathol 24: 67-72.
6. de Nooij-van Dalen AG, van Dongen GA, Smeets SJ, Nieuwenhuis EJ, Stigter-van Walsum M, Snow GB, Brakenhoff RH. 2003. Characterization of the human Ly-6 antigens, the newly annotated member Ly-6K included, as molecular markers for head-and-neck squamous cell carcinoma. Int J Cancer 103: 768-774.
7. Elsamman EM, Fukumori T, Tanimoto S, Nakanishi R, Takahashi M, Toida K, Kanayama HO. 2006. The expression of prostate stem cell antigen in human clear cell renal cell carcinoma: A quantitative reverse transcriptase-polymerase chain reaction analysis. BJU Int 98: 668-673.
8. Feng HC, Tsao SW, Ngan HY, Xue WC, Kwan HS, Siu MK, Liao XY, Wong E, Cheung AN. 2008. Overexpression of prostate stem cell antigen is associated with gestational trophoblastic neoplasia. Histopathology 52: 167-174.
9. Geiger KD, Hendruschk S, Rieber EP, Morgenroth A, Weigle B, Juratli T, Senner V, Schackert G, Temme A. 2011. The prostate stem cell antigen represents a novel glioma-associated antigen. Oncol Rep 26: 13-21.
10. Ghosh M, Koike N, Yanagimoto G, Tsunoda S, Kaul S, Hirano T, Emura F, Kashiwagi H, Kawamoto T, Ohkohchi N, Saijo K, Ohno T, Miwa M, Todoroki T. 2004. Establishment and characterization of unique human gallbladder cancer cell lines. Int J Oncol 24: 1189-1196.
11. Goldin RD, Roa JC. 2009. Gallbladder cancer: A morphological and molecular update. Histopathology 55: 218-229.
12. Gourgiotis S, Kocher HM, Solaini L, Yarollahi A, Tsiambas E, Salemis NS. 2008. Gallbladder cancer. Am J Surg 196: 252-264.
13. Gu Z, Thomas G, Yamashiro J, Shintaku IP, Dorey F, Raitano A, Witte ON, Said JW, Loda M, Reiter RE. 2000. Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer. Oncogene 19: 1288-1296.
14. Gu Z, Yamashiro J, Kono E, Reiter RE. 2005. Anti-prostate stem cell antigen monoclonal antibody 1G8 induces cell death in vitro and inhibits tumor growth in vivo via a Fc-independent mechanism. Cancer Res 65: 9495-9500.
15. Homma S, Hasumura S, Nagamori S, Kameda H. 1988. Establishment and characterization of a human gall bladder carcinoma cell line NOZ. Hum Cell 1: 95-97.
16. Hsing AW, Gao YT, Han TQ, Rashid A, Sakoda LC, Wang BS, Shen MC, Zhang BH, Niwa S, Chen J, Fraumeni JF, Jr. 2007. Gallstones and the risk of biliary tract cancer: A population-based study in China. Br J Cancer 97: 1577-1582.
17. Jain A, Lam A, Vivanco I, Carey MF, Reiter RE. 2002. Identification of an androgen-dependent enhancer within the prostate stem cell antigen gene. Mol Endocrinol 16: 2323-2337.
18. Järvi O, K Laurén P. 1967. Intestinal metaplasia in the mucosa of the gallbladder and common bile duct with additional observations on pancreas heterotopy. Ann Med Exp Biol Fenn 45: 213-223.
19. Kang CM, Kim KS, Choi JS, Lee WJ, Kim BR. 2007. Gallbladder carcinoma associated with anomalous pancreaticobiliary duct junction. Can J Gastroenterol 21: 383-387.
20. Kawaguchi T, Sho M, Tojo T, Yamato I, Nomi T, Hotta K, Hamada K, Suzaki Y, Sugiura S, Kushibe K, Nakajima Y, Taniguchi S. 2010. Clinical significance of prostate stem cell antigen expression in non-small cell lung cancer. Jpn J Clin Oncol 40: 319-326.
21. Koike N, Todoroki T, Kawamoto T, Yoshida S, Kashiwagi H, Fukao K, Ohno T, Watanabe T. 1998. The invasion potentials of human biliary tract carcinoma cell lines: Correlation between invasiveness and morphologic characteristics. Int J Oncol 13: 1269-1274.
22. Koyama S. 2004. Enhanced cell surface expression of matrix metalloproteinases and their inhibitors, and tumor-induced host response in progression of human gastric carcinoma. Dig Dis Sci 49: 1621-1630.
23. Koyama S, Yoshioka T, Mizushima A, Kawakita I, Yamagata S, Fukutomi H, Sakita T, Kondo I, Kikuchi M. 1980. Establishment of a cell line (G-415) from a human gallbladder carcinoma. Gann 71: 574-575.
24. Lazcano-Ponce EC, Miquel JF, Muñoz N, Herrero R, Ferrecio C, Wistuba II, Alonso de Ruiz P, Aristi Urista G, Nervi F. 2001. Epidemiology and molecular pathology of gallbladder cancer. CA Cancer J Clin 51: 349-364.
25. Randi G, Franceschi S, La Vecchia C. 2006. Gallbladder cancer worldwide: Geographical distribution and risk factors. Int J Cancer 118: 1591-1602.
26. Rashid A. 2002. Cellular and molecular biology of biliary tract cancers. Surg Oncol Clin N Am 11: 995-1009.
27. Reiter RE, Gu Z, Watabe T, Thomas G, Szigeti K, Davis E, Wahl M, Nisitani S, Yamashiro J, Le Beau MM, Loda M, Witte ON. 1998. Prostate stem cell antigen: A cell surface marker overexpressed in prostate cancer. Proc Natl Acad Sci USA 95: 1735-1740.
28. Roa I, Araya JC, Wistuba I, Villaseca M, de Aretxabala X, Burgos L. 1994. Gallbladder cancer in the IX Region of Chile. Impact of the anatomopathological study of 474 cases. Rev Med Chil 122: 1248-1256.
29. Saeki N, Gu J, Yoshida T, Wu X. 2010. Prostate stem cell antigen: A Jekyll and Hyde molecule? Clin Cancer Res 16: 3533-3538.
30. Saffran DC, Raitano AB, Hubert RS, Witte ON, Reiter RE, Jakobovits A. 2001. Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts. Proc Natl Acad Sci USA 98: 2658-2663.
31. Sakamoto H, Yoshimura K, Saeki N, Katai H, Shimoda T, Matsuno Y, Saito D, Sugimura H, Tanioka F, Kato S, Matsukura N, Matsuda N, Nakamura T, Hyodo I, Nishina T, Yasui W, Hirose H, Hayashi M, Toshiro E, Ohnami S, Sekine A, Sato Y, Totsuka H, Ando M, Takemura R, Takahashi Y, Ohdaira M, Aoki K, Honmyo I, Chiku S, Aoyagi K, Sasaki H, Ohnami S, Yanagihara K, Yoon KA, Kook MC, Lee YS, Park SR, Kim CG, Choi IJ, Yoshida T, Nakamura Y, Hirohashi S. 2008. Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer. Nat Genet 40: 730-740.
32. Sasatomi E, Tokunaga O, Miyazaki K. 2000. Precancerous conditions of gallbladder carcinoma: Overview of histopathologic characteristics and molecular genetic findings. J Hepatobiliary Pancreat Surg 7: 556-567.
33. Sharom FJ, Radeva G. 2004. GPI-anchored protein cleavage in the regulation of transmembrane signals. Subcell Biochem 37: 285-315.
34. Tazuma S, Kajiyama G. 2001. Carcinogenesis of malignant lesions of the gall bladder. The impact of chronic inflammation and gallstones. Langenbecks Arch Surg 386: 224-229.
35. Tran CP, Lin C, Yamashiro J, Reiter RE. 2002. Prostate stem cell antigen is a marker of late intermediate prostate epithelial cells. Mol Cancer Res 1: 113-121.
36. Wistuba II, Tang M, Maitra A, Alvarez H, Troncoso P, Pimentel F, Gazdar AF. 2001. Genome-wide allelotyping analysis reveals multiple sites of allelic loss in gallbladder carcinoma. Cancer Res 61: 3795-3800.
37. Wistuba II, Gazdar AF. 2004. Gallbladder cancer: Lessons from a rare tumour. Nat Rev Cancer 4: 695-706.
38. Yamada N, Chung YS, Ohtani H, Ikeda H, Onoda N, Sawada T, Nishiguchi Y, Hasuma T, Sowa M. 1997. Establishment and characterization of a new human gallbladder carcinoma cell line (OCUG-1) producing TA-4. Int J Oncol 10: 1251-1255.
39. Yanagihara K, Seyama T, Tsumuraya M, Kamada N, Yokoro K. 1991. Establishment and characterization of human signet ring cell gastric carcinoma cell lines with amplification of the c-myc oncogene. Cancer Res 51: 381-386.
40. Yanagihara K, Kamada N, Tsumuraya M, Amano F. 1993. Establishment and characterization of a human gastric scirrhous carcinoma cell line in serum-free chemically defined medium. Int J Cancer 54: 200-207.
41. Yanagihara K, Tanaka H, Takigahira M, Ino Y, Yamaguchi Y, Toge T, Sugano K, Hirohashi S. 2004. Establishment of two cell lines from human gastric scirrhous carcinoma that possess the potential to metastasize spontaneously in nude mice. Cancer Sci 95: 575-582.